Importantly, there is compelling evidence that the circadian clock in GBM cells influences the function and composition of GBM-associated immune cells95, highlighting a promising opportunity for applying immune-chronotherapy strategies in GBM. This evidence concerns the gene CLOCK and glioblastoma.